{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:41:28Z","timestamp":1767825688227,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the National Science Foundation of China","award":["82102150"],"award-info":[{"award-number":["82102150"]}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20210968"],"award-info":[{"award-number":["BK20210968"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2016789"],"award-info":[{"award-number":["BE2016789"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-022-08914-0","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T04:03:41Z","timestamp":1655352221000},"page":"8326-8338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study"],"prefix":"10.1007","volume":"32","author":[{"given":"Chen Yu","family":"Jiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gu Wei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8878-7332","authenticated-orcid":false,"given":"Xiang Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"key":"8914_CR1","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ (2014) Cholangiocarcinoma. Lancet 383:2168\u20132179","journal-title":"Lancet"},{"key":"8914_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"30","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX (2021) Biliary tract cancer. Lancet 30:428\u2013444","journal-title":"Lancet"},{"key":"8914_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI et al (2021) Cholangiocarcinoma. Nat Rev Dis Primers 7:65","journal-title":"Nat Rev Dis Primers"},{"key":"8914_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"8914_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/jhbp.154","volume":"22","author":"S Aishima","year":"2015","unstructured":"Aishima S, Oda Y (2015) Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type. J Hepatobiliary Pancreat Sci 22:94\u2013100","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"8914_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bpg.2015.02.006","volume":"29","author":"Y Nakanuma","year":"2015","unstructured":"Nakanuma Y, Kakuda Y (2015) Pathologic classification of cholangiocarcinoma: new concepts. Best Pract Res Clin Gastroenterol 29:277\u2013293","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"8914_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.21037\/hbsn.2016.11.04","volume":"6","author":"S Vijgen","year":"2017","unstructured":"Vijgen S, Terris B, Rubbia-Brandt L (2017) Pathology of intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr 6:22\u201334","journal-title":"Hepatobiliary Surg Nutr"},{"key":"8914_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jhep.2019.11.020","volume":"72","author":"V Mazzaferro","year":"2020","unstructured":"Mazzaferro V, Gorgen A, Roayaie S, Droz Dit Busset M, Sapisochin G (2020) Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol 72:364\u2013377","journal-title":"J Hepatol"},{"key":"8914_CR9","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1245\/s10434-020-09393-7","volume":"28","author":"DI Tsilimigras","year":"2021","unstructured":"Tsilimigras DI, Hyer JM, Paredes AZ et al (2021) Tumor burden dictates prognosis among patients undergoing resection of intrahepatic cholangiocarcinoma: a tool to guide post-resection adjuvant chemotherapy? Ann Surg Oncol 28:1970\u20131978","journal-title":"Ann Surg Oncol"},{"key":"8914_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB et al (2017) The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging. CA Cancer J Clin 67:93\u201399","journal-title":"CA Cancer J Clin"},{"key":"8914_CR11","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1200\/JCO.2012.41.5984","volume":"31","author":"Y Wang","year":"2013","unstructured":"Wang Y, Li J, Xia Y et al (2013) Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 31:1188\u20131195","journal-title":"J Clin Oncol"},{"key":"8914_CR12","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jamasurg.2013.5168","volume":"149","author":"O Hyder","year":"2014","unstructured":"Hyder O, Marques H, Pulitano C et al (2014) A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg 149:432\u2013438","journal-title":"JAMA Surg"},{"key":"8914_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2017.0117","volume":"152","author":"M Raoof","year":"2017","unstructured":"Raoof M, Dumitra S, Ituarte PHG et al (2017) Development and validation of a prognostic score for intrahepatic cholangiocarcinoma. JAMA Surg 152:e170117","journal-title":"JAMA Surg"},{"key":"8914_CR14","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1093\/annonc\/mdq650","volume":"22","author":"W Jiang","year":"2011","unstructured":"Jiang W, Zeng ZC, Tang ZY et al (2011) A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: the Fudan score. Ann Oncol 22:1644\u20131652","journal-title":"Ann Oncol"},{"key":"8914_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00330-015-3846-5","volume":"26","author":"J Koh","year":"2016","unstructured":"Koh J, Chung YE, Nahm JH et al (2016) Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI. Eur Radiol 26:407\u2013416","journal-title":"Eur Radiol"},{"key":"8914_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1148\/radiol.11101777","volume":"260","author":"SA Kim","year":"2011","unstructured":"Kim SA, Lee JM, Lee KB et al (2011) Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings. Radiology 260:148\u2013157","journal-title":"Radiology"},{"key":"8914_CR17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1148\/radiol.12112308","volume":"264","author":"Y Kang","year":"2012","unstructured":"Kang Y, Lee JM, Kim SH, Han JK, Choi BI (2012) Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology 264:751\u2013760","journal-title":"Radiology"},{"key":"8914_CR18","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41379-020-00656-y","volume":"34","author":"N Guedj","year":"2021","unstructured":"Guedj N, Blaise L, Cauchy F, Albuquerque M, Soubrane O, Paradis V (2021) Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma. Mod Pathol 34:408\u2013416","journal-title":"Mod Pathol"},{"key":"8914_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.trecan.2018.01.007","volume":"4","author":"D H\u00f8gdall","year":"2018","unstructured":"H\u00f8gdall D, Lewinska M, Andersen JB (2018) Desmoplastic tumor microenvironment and immunotherapy in cholangiocarcinoma. Trends Cancer 4:239\u2013255","journal-title":"Trends Cancer"},{"key":"8914_CR20","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.3390\/ijms19102885","volume":"19","author":"A Gentilini","year":"2018","unstructured":"Gentilini A, Pastore M, Marra F et al (2018) The role of stroma in cholangiocarcinoma: the intriguing interplay between fibroblastic component, immune cell subsets and tumor epithelium. Int J Mol Sci 19:2885","journal-title":"Int J Mol Sci"},{"key":"8914_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4254\/wjh.v9.i9.455","volume":"9","author":"A Gentilini","year":"2017","unstructured":"Gentilini A, Pastore M, Marra F, Raggi C (2017) Tumor reactive stroma in cholangiocarcinoma: the fuel behind cancer aggressiveness. World J Hepatol 9:455\u2013468","journal-title":"World J Hepatol"},{"key":"8914_CR22","doi-asserted-by":"publisher","first-page":"W603","DOI":"10.2214\/AJR.12.10262","volume":"201","author":"HT Jeong","year":"2013","unstructured":"Jeong HT, Kim MJ, Chung YE, Choi JY, Park YN, Kim KW (2013) Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. AJR Am J Roentgenol 201:W603\u2013W611","journal-title":"AJR Am J Roentgenol"},{"key":"8914_CR23","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s00330-016-4386-3","volume":"27","author":"N Fujita","year":"2017","unstructured":"Fujita N, Asayama Y, Nishie A et al (2017) Mass-forming intrahepatic cholangiocarcinoma: enhancement patterns in the arterial phase of dynamic hepatic CT - Correlation with clinicopathological findings. Eur Radiol 27:498\u2013506","journal-title":"Eur Radiol"},{"key":"8914_CR24","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP (2015) Nomograms in oncology: more than meets the eye. Lancet Oncol 16:e173\u2013e180","journal-title":"Lancet Oncol"},{"key":"8914_CR25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1148\/radiol.2018181408","volume":"290","author":"GW Ji","year":"2019","unstructured":"Ji GW, Zhang YD, Zhang H et al (2019) Biliary tract cancer at CT: a radiomics-based model to predict lymph node metastasis and survival outcomes. Radiology 290:90\u201398","journal-title":"Radiology"},{"key":"8914_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejrad.2019.01.037","volume":"113","author":"CEP Panick","year":"2019","unstructured":"Panick CEP, Ward RD, Coppa C, Liu PS (2019) Hepatic capsular retraction: an updated MR imaging review. Eur J Radiol 113:15\u201323","journal-title":"Eur J Radiol"},{"key":"8914_CR27","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1148\/radiol.2018181485","volume":"290","author":"JH Min","year":"2019","unstructured":"Min JH, Kim YK, Choi SY et al (2019) Intrahepatic mass-forming cholangiocarcinoma: arterial enhancement patterns at MRI and prognosis. Radiology 290:691\u2013699","journal-title":"Radiology"},{"key":"8914_CR28","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.7150\/jca.25339","volume":"9","author":"C He","year":"2018","unstructured":"He C, Zhang Y, Song Y et al (2018) Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma. J Cancer 9:3117\u20133128","journal-title":"J Cancer"},{"key":"8914_CR29","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00535-006-1877-z","volume":"41","author":"S Miwa","year":"2006","unstructured":"Miwa S, Miyagawa S, Kobayashi A et al (2006) Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 41:893\u2013900","journal-title":"J Gastroenterol"},{"key":"8914_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","volume":"149","author":"MN Mavros","year":"2014","unstructured":"Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM (2014) Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 149:565\u2013574","journal-title":"JAMA Surg"},{"key":"8914_CR31","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s11605-018-4052-y","volume":"23","author":"P Addeo","year":"2019","unstructured":"Addeo P, Jedidi I, Locicero A et al (2019) prognostic impact of tumor multinodularity in intrahepatic cholangiocarcinoma. J Gastrointest Surg 23:1801\u20131809","journal-title":"J Gastrointest Surg"},{"key":"8914_CR32","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1245\/s10434-018-6669-1","volume":"25","author":"S Conci","year":"2018","unstructured":"Conci S, Ruzzenente A, Vigan\u00f2 L et al (2018) Patterns of distribution of hepatic nodules (single, satellites or multifocal) in intrahepatic cholangiocarcinoma: prognostic impact after surgery. Ann Surg Oncol 25:3719\u20133727","journal-title":"Ann Surg Oncol"},{"key":"8914_CR33","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s13244-016-0520-7","volume":"7","author":"GX Tan","year":"2016","unstructured":"Tan GX, Miranda R, Sutherland T (2016) Causes of hepatic capsular retraction: a pictorial essay. Insights Imaging 7:831\u2013840","journal-title":"Insights Imaging"},{"key":"8914_CR34","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1200\/JCO.18.02178","volume":"37","author":"RT Shroff","year":"2019","unstructured":"Shroff RT, Kennedy EB, Bachini M et al (2019) Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline. J Clin Oncol 37:1015\u20131027","journal-title":"J Clin Oncol"},{"key":"8914_CR35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41416-018-0334-0","volume":"120","author":"V Mazzaferro","year":"2019","unstructured":"Mazzaferro V, El-Rayes BF, Droz Dit Busset M et al (2019) Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma. Br J Cancer 120:165\u2013171","journal-title":"Br J Cancer"},{"key":"8914_CR36","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamaoncol.2020.0930","volume":"6","author":"RD Kim","year":"2020","unstructured":"Kim RD, Chung V, Alese OB et al (2020) A phase 2 multi-institutional study of nivolumab for patients with advanced refractory biliary tract cancer. JAMA Oncol 6:888\u2013894","journal-title":"JAMA Oncol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-08914-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-022-08914-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-08914-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T16:08:12Z","timestamp":1669651692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-022-08914-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8914"],"URL":"https:\/\/doi.org\/10.1007\/s00330-022-08914-0","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,16]]},"assertion":[{"value":"7 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Xiang Cheng Li.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors has significant statistical expertise: Hui Zhang.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the institutional review board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional review board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 retrospective\u2022 diagnostic or prognostic study\u2022 multicenter study","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}